Estimates Revisions Takeda Pharmaceutical Company Limited Börse Stuttgart
Stocks
TKD
JP3463000004
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.99 EUR | -0.92% |
|
-4.10% | +12.28% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4502 Stock
- TKD Stock
- Consensus Takeda Pharmaceutical Company Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
